Findings on Psoriatic Arthritis Detailed by Investigators at Department of Rheumatology [Tumour Necrosis Factor Inhibitor Dose Adaptation In Psoriatic Arthritis and Axial Spondyloarthritis (Tapas): a Retrospective Cohort Study]

MLA

“Findings on Psoriatic Arthritis Detailed by Investigators at Department of Rheumatology [Tumour Necrosis Factor Inhibitor Dose Adaptation In Psoriatic Arthritis and Axial Spondyloarthritis (Tapas): A Retrospective Cohort Study].” Health & Medicine Week, 3 June 2022, p. 2186. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.705343785&authtype=sso&custid=ns315887.

APA

Findings on Psoriatic Arthritis Detailed by Investigators at Department of Rheumatology [Tumour Necrosis Factor Inhibitor Dose Adaptation In Psoriatic Arthritis and Axial Spondyloarthritis (Tapas): a Retrospective Cohort Study]. (2022, June 3). Health & Medicine Week, 2186.

Chicago

Health & Medicine Week. 2022. “Findings on Psoriatic Arthritis Detailed by Investigators at Department of Rheumatology [Tumour Necrosis Factor Inhibitor Dose Adaptation In Psoriatic Arthritis and Axial Spondyloarthritis (Tapas): A Retrospective Cohort Study],” June 3. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.705343785&authtype=sso&custid=ns315887.